CLINICAL_TRIALS
trial_result
· 2024-08-07
Clinical Trial Update: Imipenem/Cilastatin/Relebactam PK in ECMO [Phase 1]
Summary
Phase 1 study assessing the pharmacokinetics of imipenem/cilastatin/relebactam in patients on ECMO with sepsis; the study is completed, with results posted in 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joseph L. Kuti, PharmD | Conditions: Sepsis | Phase 1 | Status: COMPLETED | Results posted: 2024-08-07